Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL2474192

O=C([O-])C(O)C(O)C(=O)O.[Li+]

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.67
LMNA P02545 3/20 0.45
CYP3A4 P08684 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
TP53 P04637 1/20 0.37
CYP2C9 P11712 1/20 0.36
PDE4A P27815 1/20 0.36
CA4 P22748 2/20 0.35
NFKB1 P19838 1/20 0.34
CYP2C19 P33261 1/20 0.34
OR51E2 Q9H255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL4167271 0.97 TSHR (0.62) TSHRLMNACYP3A4TDP1BLM
Cadaverine Tartrate SCHEMBL3209520 0.93 TSHR (0.67) TSHRLMNACYP3A4TDP1BLM
Cadaverine Tartrate SCHEMBL2896395 0.93 TSHR (0.67) TSHRLMNACYP3A4TDP1BLM
Cadaverine Tartrate SCHEMBL11054858 0.93 TSHR (0.67) TSHRLMNACYP3A4TDP1BLM
Cadaverine Tartrate SCHEMBL7510054 0.93 TSHR (0.67) TSHRLMNACYP3A4TDP1BLM
Cadaverine Tartrate SCHEMBL6229409 0.93 TSHR (0.67) TSHRLMNACYP3A4TDP1BLM
Cadaverine Tartrate SCHEMBL21569383 0.93 TSHR (0.67) TSHRLMNACYP3A4TDP1BLM
Cadaverine Tartrate SCHEMBL21569402 0.93 TSHR (0.67) TSHRLMNACYP3A4TDP1BLM
Cadaverine Tartrate SCHEMBL20565539 0.93 TSHR (0.67) TSHRLMNACYP3A4TDP1BLM
Cadaverine Tartrate SCHEMBL8467361 0.93 TSHR (0.67) TSHRLMNACYP3A4TDP1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110534730-A The preparation method of lithium titanate material GOLINK TECH HUZHOU CO LTD 2019-12-03 CN claimed
US-20180064755-A1 COMPOSITIONS AND METHODS FOR TREATING DRUG ADDICTION FORBES, JOELLE MICHELE (FR) 2018-03-08 US claimed
US-20150044302-A1 COMPOSITIONS AND METHODS FOR PROMOTING APPETITE SUPPRESSION USING ALKALI METALS ASHBERRY INTERNATIONAL LIMITED (VG) 2015-02-12 US claimed
US-20110244055-A1 COMPOSITIONS AND METHODS FOR PROMOTING APPETITE SUPPRESSION USING ALKALI METALS FORBES, JOELLE MICHELE (FR) 2011-10-06 US claimed
EP-2371372-A1 Methods of promoting appetite suppression using alkali metals Forbes, Anrold (FR) 2011-10-05 EP claimed
US-7012053-B1 Fabric care composition and method comprising a fabric care polysaccharide and wrinkle control agent THE PROCTER & GAMBLE COMPANY (US) 2006-03-14 US claimed
CN-1665686-A Method of conditioning a lithographic printing plate FLINT INK CORP (US) 2005-09-07 CN claimed
EP-0988364-B1 UNCOMPLEXED CYCLODEXTRIN COMPOSITIONS FOR ODOR AND WRINKLE CONTROL PROCTER & GAMBLE (US) 2005-08-24 EP claimed
EP-1515856-A1 METHOD OF CONDITIONING A LITHOGRAPHIC PRINTING PLATE Flint Ink Corporation (US) 2005-03-23 EP claimed
US-6854391-B2 Lithographic printing method and materials FLINT INK CORPORATION (US) 2005-02-15 US claimed
EP-0988364-A1 UNCOMPLEXED CYCLODEXTRIN COMPOSITIONS FOR ODOR AND WRINKLE CONTROL THE PROCTER & GAMBLE COMPANY (US) 2000-03-29 EP claimed
US-6001343-A STABLE, AQUEOUS ODOR-ABSORBING COMPOSITION SUCH AS FABRIC SPRAY; SOLUBILIZED, UNCOMPLEXED CYCLODEXTRIN AND COMPATIBLE SURFACTANT, PERFUME, CHELATOR, SALT, ENZYME, ANTIWRINKLE AGENT, PRESERVATIVE AND POLYOL; IMPROVED ANTIMICROBIAL ACTION THE PROCTER & GAMBLE COMPANY (US) 1999-12-14 US claimed
WO-1999055814-A1 IMPROVED UNCOMPLEXED CYCLODEXTRIN COMPOSITIONS FOR ODOR AND WRINKLE CONTROL THE PROCTER & GAMBLE COMPANY (US) 1999-11-04 WO claimed
WO-1999055953-A1 FABRIC WRINKLE CONTROL COMPOSITION AND METHOD THE PROCTER & GAMBLE COMPANY (US) 1999-11-04 WO claimed
US-5968404-A ODER ABSORBERS AND WRINKLE RESISTANCE FOR FABRICS THE PROCTER & GAMBLE COMPANY (US) 1999-10-19 US claimed
WO-1998056890-A1 UNCOMPLEXED CYCLODEXTRIN COMPOSITIONS FOR ODOR AND WRINKLE CONTROL THE PROCTER & GAMBLE COMPANY (US) 1998-12-17 WO claimed
EP-0234733-B1 PHARMACEUTICAL COMPOSITIONS SCOTIA PHARMACEUTICALS LIMITED (GB) 1991-11-13 EP claimed
US-4810497-A Pharmaceutical compositions EFAMOL LIMITED (GB) 1989-03-07 US claimed
EP-0234733-A1 Pharmaceutical compositions SCOTIA PHARMACEUTICALS LIMITED (GB) 1987-09-02 EP claimed
US-3994729-A DIALDEHYDES, FIXING WITH THIOSULFATES, ALUMINUM SALT, TARTARIC ACID OR CITRIC ACID FUJI PHOTO FILM CO., LTD. (JA) 1976-11-30 US claimed